Entyvio for Crohn's Disease

ENTYVIO made remission real for many people with moderate to severe Crohn's disease

In three clinical trials, ENTYVIO delivered results for adult patients with moderate to severe Crohn's disease when other medicines had not worked well enough or could not be tolerated.

The first and second studies evaluated the number of patients who achieved remission on ENTYVIO versus placebo at Week 6; additionally, the second study also evaluated remission at Week 10. The third study enrolled adults who had a previous response to ENTYVIO at Week 6 and evaluated remission at Week 52.

Results were seen as early as 6 weeks

ENTYVIO helped

MORE THAN TWICE

as many people
achieve remission vs placebo

At 6 weeks of treatment, 15% of people on ENTYVIO achieved remission* compared to 7% of people on placebo.

Long-term remission

ENTYVIO helped

ALMOST TWICE AS MANY

people achieve remission
at 1 year vs placebo

39% of people on ENTYVIO achieved remission* at 1 year of treatment, compared to 22% of people on placebo.

IMPORTANT SAFETY INFORMATION

Do not receive ENTYVIO if you have had an allergic reaction to ENTYVIO or any of its ingredients.
ENTYVIO may cause serious side effects, including:
- Infusion-related and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You may need treatment if you have an allergic reaction. Tell your healthcare provider or get immediate medical help if you get any of these symptoms during or after an infusion of ENTYVIO; rash, itching, swelling of your lips, tongue, throat, or face, shortness of breath or trouble breathing, wheezing, dizziness, feeling hot, or palpitations (feeling like your heart is racing).

Please see additional Important Safety Information below.

Results without steroids

ENTYVIO helped

TWICE AS MANY

people achieve remission without depending on steroids vs placebo

32% of people on ENTYVIO achieved remission without the use of steroids at 1 year compared to 16% of people on placebo.

Some patients were on steroids at the beginning of the study. ENTYVIO helped some of these patients achieve remission without the use of steroids at Week 52.

*Remission is a measure to determine when a patient with Crohn's is experiencing a few to no symptoms and an improvement in their condition.

In the ENTYVIO clinical studies, clinical remission was defined and measured by improvement in the CDAI score, a tool that assesses the number of liquid or very soft stools, abdominal pain, and other measures of disease activity.

Ask your doctor if ENTYVIO is right for you.

Sign up for EntyvioConnect

Ready to access everything EntyvioConnect has to offer? Sign up today!

How ENTYVIO infusion works and what to expect.

What's an ENTYVIO infusion like?

Questions about infusions? Here's how it works.

Learn more

What's it like to get an ENTYVIO infusion?

Here's what you can expect when you take ENTYVIO.

Learn more

IMPORTANT SAFETY INFORMATION

Do not receive ENTYVIO if you have had an allergic reaction to ENTYVIO or any of its ingredients.
ENTYVIO may cause serious side effects, including:
- Infusion-related and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You may need treatment if you have an allergic reaction. Tell your healthcare provider or get immediate medical help if you get any of these symptoms during or after an infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat or face, shortness of breath or trouble breathing, wheezing, dizziness, feeling hot, or palpitations (feel like your heart is racing).
- Infections. ENTYVIO may increase your risk of getting a serious infection. Before receiving and during treatment with ENTYVIO, tell your healthcare provider if you think you have an infection or symptoms of an infection, such as fever, chills, muscle aches, cough, shortness of breath, runny nose, sore throat, red or painful skin or sores on your body, tiredness, or pain during urination.
- Progressive Multifocal Leukoencephalopathy (PML). People with weakened immune systems can get progressive multifocal leukoencephalopathy (PML) (a rare, serious brain infection caused by a virus). Although unlikely while receiving ENTYVIO, a risk of PML cannot be ruled out. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML. Tell your healthcare provider right away if you have any of the following symptoms: confusion or problems thinking, loss of balance, change in the way you walk or talk, decreased strength or weakness on one side of the body, blurred vision, or loss of vision.
- Liver problems can happen in people who receive ENTYVIO. Tell your healthcare provider right away if you have any of the following symptoms: tiredness, loss of appetite, pain on the right side of your abdomen, dark urine, or yellowing of the skin and eyes (jaundice).
The most common side effects of ENTYVIO include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, and pain in extremities. These are not all the possible side effects of ENTYVIO. Call your healthcare provider for medical advice about side effects.
Before receiving ENTYVIO, tell your healthcare provider about all of your medical conditions, including if you: have or think you may have an infection or have infections that keep coming back; have liver problems; have tuberculosis (TB) or have been in close contact with someone with TB; have recently received or are scheduled to receive a vaccine; or if you are pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.

Please see accompanying full Prescribing Information, including the Medication Guide, for ENTYVIO and talk with your healthcare provider.

ENTYVIO is available for intravenous (IV) injection: 300 mg vedolizumab.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-10881-800-FDA-1088.

What is ENTYVIO^® (vedolizumab)?

ENTYVIO is a prescription medicine used in adults for the treatment of:

moderately to severely active ulcerative colitis (UC).
moderately to severely active Crohn’s disease (CD).

It is not known if ENTYVIO is safe and effective in children under 18 years of age.

IMPORTANT SAFETY INFORMATION

Do not receive ENTYVIO if you have had an allergic reaction to ENTYVIO or any of its ingredients.

ENTYVIO may cause serious side effects, including:

Infusion-related and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You may need treatment if you have an allergic reaction. Tell your healthcare provider or get immediate medical help if you get any of these symptoms during or after an infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat or face, shortness of breath or trouble breathing, wheezing, dizziness, feeling hot, or palpitations (feel like your heart is racing).
Infections. ENTYVIO may increase your risk of getting a serious infection. Before receiving and during treatment with ENTYVIO, tell your healthcare provider if you think you have an infection or symptoms of an infection, such as fever, chills, muscle aches, cough, shortness of breath, runny nose, sore throat, red or painful skin or sores on your body, tiredness, or pain during urination.
Progressive Multifocal Leukoencephalopathy (PML). People with weakened immune systems can get progressive multifocal leukoencephalopathy (PML) (a rare, serious brain infection caused by a virus). Although unlikely while receiving ENTYVIO, a risk of PML cannot be ruled out. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML. Tell your healthcare provider right away if you have any of the following symptoms: confusion or problems thinking, loss of balance, change in the way you walk or talk, decreased strength or weakness on one side of the body, blurred vision, or loss of vision.
Liver problems can happen in people who receive ENTYVIO. Tell your healthcare provider right away if you have any of the following symptoms: tiredness, loss of appetite, pain on the right side of your abdomen, dark urine, or yellowing of the skin and eyes (jaundice).

The most common side effects of ENTYVIO include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, and pain in extremities. These are not all the possible side effects of ENTYVIO. Call your healthcare provider for medical advice about side effects.

Before receiving ENTYVIO, tell your healthcare provider about all of your medical conditions, including if you: have or think you may have an infection or have infections that keep coming back; have liver problems; have tuberculosis (TB) or have been in close contact with someone with TB; have recently received or are scheduled to receive a vaccine; or if you are pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.

Please see accompanying full Prescribing Information, including the Medication Guide, for ENTYVIO and talk with your healthcare provider.

ENTYVIO is available for intravenous (IV) injection: 300 mg vedolizumab.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-10881-800-FDA-1088.

What is ENTYVIO^® (vedolizumab)?

ENTYVIO is a prescription medicine used in adults for the treatment of:

moderately to severely active ulcerative colitis (UC).

moderately to severely active Crohn’s disease (CD).

It is not known if ENTYVIO is safe and effective in children under 18 years of age.

Entyvio for Crohn's Disease

ENTYVIO made remission real for many people with moderate to severe Crohn's disease

Results were seen as early as 6 weeks

Long-term remission

IMPORTANT SAFETY INFORMATION

Results without steroids

Ask your doctor if ENTYVIO is right for you.

Sign up for EntyvioConnect

What's an ENTYVIO infusion like?

What's it like to get an ENTYVIO infusion?

You are About to Leave this Website and Enter a Website Operated by an Independent Third Party

You are about to leave this website.

Share with Your Friends and Family: